BofA Securities Upgrades Cellebrite (CLBT) to Buy, 'Solid 4Q23 results and improved business momentum in 2024'
Tweet Send to a Friend
(Updated - February 16, 2024 8:27 AM EST)
BofA Securities analyst Tomer Zilberman upgraded Cellebrite (NASDAQ: CLBT) from Neutral ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
BofA Securities analyst Tomer Zilberman upgraded Cellebrite (NASDAQ: CLBT) from Neutral ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
